China Transthyretin Market Research Report 2018

February 2018 | 101 pages | ID: C97A9B94E6AEN
QYResearch

Abstracts

The global Transthyretin market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Transthyretin development status and future trend in China, focuses on top players in China, also splits Transthyretin by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Alnylam Pharmaceuticals Inc
• Arcturus Therapeutics Inc
• Ionis Pharmaceuticals Inc
• Neurimmune Holding AG
• Pfizer Inc
• Prothena Corp Plc
• Regeneron Pharmaceuticals Inc

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• AG-10
• ALN-TTRsc02
• CRX-1008
• EDE-1307
• Inotersen Sodium
• Others

On the basis of the end users/application, this report covers

• Familial Amyloid Neuropathies
• Alzheimer's Disease
• Cardomyopathy
• Neuropathy
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Transthyretin Market Research Report 2017

1 TRANSTHYRETIN OVERVIEW

1.1 Product Overview and Scope of Transthyretin
1.2 Classification of Transthyretin by Product Category
  1.2.1 China Transthyretin Sales (K Pcs) Comparison by Type (2012-2022)
  1.2.2 China Transthyretin Sales (K Pcs) Market Share by Type in 2016
  1.2.3 AG-10
  1.2.4 ALN-TTRsc02
  1.2.5 CRX-1008
  1.2.6 EDE-1307
  1.2.7 Inotersen Sodium
  1.2.8 Others
1.3 China Transthyretin Market by Application/End Users
  1.3.1 China Transthyretin Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Familial Amyloid Neuropathies
  1.3.3 Alzheimer's Disease
  1.3.4 Cardomyopathy
  1.3.5 Neuropathy
  1.3.6 Others
1.4 China Transthyretin Market by Region
  1.4.1 China Transthyretin Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Transthyretin Status and Prospect (2012-2022)
  1.4.3 East China Transthyretin Status and Prospect (2012-2022)
  1.4.4 Southwest China Transthyretin Status and Prospect (2012-2022)
  1.4.5 Northeast China Transthyretin Status and Prospect (2012-2022)
  1.4.6 North China Transthyretin Status and Prospect (2012-2022)
  1.4.7 Central China Transthyretin Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Transthyretin (2012-2022)
  1.5.1 China Transthyretin Sales (K Pcs) and Growth Rate (%)(2012-2022)
  1.5.2 China Transthyretin Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA TRANSTHYRETIN MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Transthyretin Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Transthyretin Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Transthyretin Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
2.4 China Transthyretin Market Competitive Situation and Trends
  2.4.1 China Transthyretin Market Concentration Rate
  2.4.2 China Transthyretin Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Transthyretin Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA TRANSTHYRETIN SALES AND REVENUE BY REGION (2012-2017)

3.1 China Transthyretin Sales (K Pcs) and Market Share by Region (2012-2017)
3.2 China Transthyretin Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Transthyretin Price (USD/Pcs) by Regions (2012-2017)

4 CHINA TRANSTHYRETIN SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China Transthyretin Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
4.2 China Transthyretin Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Transthyretin Price (USD/Pcs) by Type (2012-2017)
4.4 China Transthyretin Sales Growth Rate (%) by Type (2012-2017)

5 CHINA TRANSTHYRETIN SALES BY APPLICATION (2012-2017)

5.1 China Transthyretin Sales (K Pcs) and Market Share by Application (2012-2017)
5.2 China Transthyretin Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA TRANSTHYRETIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Alnylam Pharmaceuticals Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Transthyretin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alnylam Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Arcturus Therapeutics Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Transthyretin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Arcturus Therapeutics Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Ionis Pharmaceuticals Inc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Transthyretin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Ionis Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Neurimmune Holding AG
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Transthyretin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Neurimmune Holding AG Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Transthyretin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Prothena Corp Plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Transthyretin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Prothena Corp Plc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Regeneron Pharmaceuticals Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Transthyretin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Regeneron Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview

7 TRANSTHYRETIN MANUFACTURING COST ANALYSIS

7.1 Transthyretin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transthyretin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Transthyretin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transthyretin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA TRANSTHYRETIN MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Transthyretin Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 China Transthyretin Sales (K Pcs) Forecast by Type (2017-2022)
11.3 China Transthyretin Sales (K Pcs) Forecast by Application (2017-2022)
11.4 China Transthyretin Sales (K Pcs) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Transthyretin Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Transthyretin Sales (K Pcs) by Application (2016-2022)
Figure Product Picture of Transthyretin
Table China Transthyretin Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Transthyretin Sales Volume Market Share by Types in 2016
Figure AG-10 Product Picture
Figure ALN-TTRsc02 Product Picture
Figure CRX-1008 Product Picture
Figure EDE-1307 Product Picture
Figure Inotersen Sodium Product Picture
Figure Others Product Picture
Figure China Transthyretin Sales (K Pcs) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Transthyretin by Application in 2016
Figure Familial Amyloid Neuropathies Examples
Table Key Downstream Customer in Familial Amyloid Neuropathies
Figure Alzheimer's Disease Examples
Table Key Downstream Customer in Alzheimer's Disease
Figure Cardomyopathy Examples
Table Key Downstream Customer in Cardomyopathy
Figure Neuropathy Examples
Table Key Downstream Customer in Neuropathy
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Transthyretin Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Transthyretin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Transthyretin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Transthyretin Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Transthyretin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Transthyretin Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Transthyretin Sales (K Pcs) and Growth Rate (%)(2012-2022)
Figure China Transthyretin Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Transthyretin Sales of Key Players/Manufacturers (2012-2017)
Table China Transthyretin Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Transthyretin Sales Share (%) by Players/Manufacturers
Figure 2017 China Transthyretin Sales Share (%) by Players/Manufacturers
Table China Transthyretin Revenue by Players/Manufacturers (2012-2017)
Table China Transthyretin Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Transthyretin Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Transthyretin Revenue Market Share (%) by Players/Manufacturers
Table China Market Transthyretin Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Transthyretin Average Price of Key Players/Manufacturers in 2016
Figure China Transthyretin Market Share of Top 3 Players/Manufacturers
Figure China Transthyretin Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Transthyretin Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Transthyretin Product Category
Table China Transthyretin Sales (K Pcs) by Regions (2012-2017)
Table China Transthyretin Sales Share (%) by Regions (2012-2017)
Figure China Transthyretin Sales Share (%) by Regions (2012-2017)
Figure China Transthyretin Sales Market Share (%) by Regions in 2016
Table China Transthyretin Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Transthyretin Revenue Market Share (%) by Regions (2012-2017)
Figure China Transthyretin Revenue Market Share (%) by Regions (2012-2017)
Figure China Transthyretin Revenue Market Share (%) by Regions in 2016
Table China Transthyretin Price (USD/Pcs) by Regions (2012-2017)
Table China Transthyretin Sales (K Pcs) by Type (2012-2017)
Table China Transthyretin Sales Share (%) by Type (2012-2017)
Figure China Transthyretin Sales Share (%) by Type (2012-2017)
Figure China Transthyretin Sales Market Share (%) by Type in 2016
Table China Transthyretin Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Transthyretin Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Transthyretin by Type (2012-2017)
Figure Revenue Market Share of Transthyretin by Type in 2016
Table China Transthyretin Price (USD/Pcs) by Types (2012-2017)
Figure China Transthyretin Sales Growth Rate (%) by Type (2012-2017)
Table China Transthyretin Sales (K Pcs) by Applications (2012-2017)
Table China Transthyretin Sales Market Share (%) by Applications (2012-2017)
Figure China Transthyretin Sales Market Share (%) by Application (2012-2017)
Figure China Transthyretin Sales Market Share (%) by Application in 2016
Table China Transthyretin Sales Growth Rate (%) by Application (2012-2017)
Figure China Transthyretin Sales Growth Rate (%) by Application (2012-2017)
Table Alnylam Pharmaceuticals Inc Transthyretin Basic Information List
Table Alnylam Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Alnylam Pharmaceuticals Inc Transthyretin Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Alnylam Pharmaceuticals Inc Transthyretin Sales Market Share (%) in China (2012-2017)
Figure Alnylam Pharmaceuticals Inc Transthyretin Revenue Market Share (%) in China (2012-2017)
Table Arcturus Therapeutics Inc Transthyretin Basic Information List
Table Arcturus Therapeutics Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Arcturus Therapeutics Inc Transthyretin Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Arcturus Therapeutics Inc Transthyretin Sales Market Share (%) in China (2012-2017)
Figure Arcturus Therapeutics Inc Transthyretin Revenue Market Share (%) in China (2012-2017)
Table Ionis Pharmaceuticals Inc Transthyretin Basic Information List
Table Ionis Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Ionis Pharmaceuticals Inc Transthyretin Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Ionis Pharmaceuticals Inc Transthyretin Sales Market Share (%) in China (2012-2017)
Figure Ionis Pharmaceuticals Inc Transthyretin Revenue Market Share (%) in China (2012-2017)
Table Neurimmune Holding AG Transthyretin Basic Information List
Table Neurimmune Holding AG Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Neurimmune Holding AG Transthyretin Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Neurimmune Holding AG Transthyretin Sales Market Share (%) in China (2012-2017)
Figure Neurimmune Holding AG Transthyretin Revenue Market Share (%) in China (2012-2017)
Table Pfizer Inc Transthyretin Basic Information List
Table Pfizer Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Pfizer Inc Transthyretin Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Pfizer Inc Transthyretin Sales Market Share (%) in China (2012-2017)
Figure Pfizer Inc Transthyretin Revenue Market Share (%) in China (2012-2017)
Table Prothena Corp Plc Transthyretin Basic Information List
Table Prothena Corp Plc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Prothena Corp Plc Transthyretin Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Prothena Corp Plc Transthyretin Sales Market Share (%) in China (2012-2017)
Figure Prothena Corp Plc Transthyretin Revenue Market Share (%) in China (2012-2017)
Table Regeneron Pharmaceuticals Inc Transthyretin Basic Information List
Table Regeneron Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Regeneron Pharmaceuticals Inc Transthyretin Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Regeneron Pharmaceuticals Inc Transthyretin Sales Market Share (%) in China (2012-2017)
Figure Regeneron Pharmaceuticals Inc Transthyretin Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transthyretin
Figure Manufacturing Process Analysis of Transthyretin
Figure Transthyretin Industrial Chain Analysis
Table Raw Materials Sources of Transthyretin Major Players/Manufacturers in 2016
Table Major Buyers of Transthyretin
Table Distributors/Traders List
Figure China Transthyretin Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure China Transthyretin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Transthyretin Price (USD/Pcs) Trend Forecast (2017-2022)
Table China Transthyretin Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Transthyretin Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Transthyretin Sales Volume Market Share Forecast by Type in 2022
Table China Transthyretin Sales (K Pcs) Forecast by Application (2017-2022)
Figure China Transthyretin Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Transthyretin Sales Volume Market Share Forecast by Application in 2022
Table China Transthyretin Sales (K Pcs) Forecast by Regions (2017-2022)
Table China Transthyretin Sales Volume Share Forecast by Regions (2017-2022)
Figure China Transthyretin Sales Volume Share Forecast by Regions (2017-2022)
Figure China Transthyretin Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources